Individualizing Antihyperglycemic Agents in Type 2 Diabetes

Duration

15 mins

Profession

Physician

# of Credits

0.25

Accreditation

Mainpro+

Expiry Date

2020-10-09

In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies.

​This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ Credit(s). Cert+ Program ID#: 190712

  • Peter Lin, MD, CCFP
  • David C.W. Lau, MD, PhD, FRCPC
  • Thomas Round, MBBS, BSc, DRCOG, MRCGP
  • David Strain, MB, ChB, BSc (Hons) MD, FRCP
  • Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC
  • Robyn L. Houlden, MD, FRCPC
  • John Axler, MD, CCFP, FCFP
  • Deanna Telner, MD, MEd, CCFP, FCFP
  • Jeffrey Habert, MD, CCFP, FCFP

Upon completion of this program, participants will be able to:

  • Determine how specific patient factors can help with the individualization of antihyperglycemic therapies


Related Courses